PCSK9 Inhibitors (e.g., Evolocumab)
Treatment for Coronary Artery Disease
Effectiveness
78%
Safety Score
65%
Clinical Trials
50
Participants
70K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
0
PCSK9 Inhibitors (e.g., Evolocumab) Outcomes
for Coronary Artery Disease
Efficacy Outcomes
Overall Effectiveness
+78%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov